• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 1.60% Nasdaq Down 0.39%

    Navidea Biopharmaceuticals, Inc (NAVB)

    -NYSE MKT
    0.84 Feb 11, 4:02PM EST
    Prev Close:0.84
    Open:N/A
    Bid:N/A
    Ask:N/A
    1y Target Est:1.83
    Beta:-0.039017
    Earnings Date:Mar 3 - Mar 7 (Est.)
    Day's Range:N/A - N/A
    52wk Range:0.75 - 2.50
    Volume:0
    Avg Vol (3m):493,937
    Market Cap:130.63M
    P/E (ttm):N/A
    EPS (ttm):-0.21
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for NAVB

    Comparison

    Symbol% ChgMkt Cap
    NAVB 0.00%130.63M
    LLY75.63B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):11.30
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.19
    Quarterly EPS Est (Dec-15) :-0.04
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Navidea Biopharmaceuticals, Inc., a precision medicine company, focuses on the development and commercialization of precision diagnostics, therapeutics, and radiopharmaceutical agents. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback